Literature DB >> 8702742

Differential utilization of Trk autophosphorylation sites.

R A Segal1, A Bhattacharyya, L A Rua, J A Alberta, R M Stephens, D R Kaplan, C D Stiles.   

Abstract

Tyrosine autophosphorylation controls the catalytic and signaling activities of the neurotrophin receptors, the Trks. To analyze the regulation of distinct tyrosine sites, we generated a panel of antibodies that report the phosphorylation state of individual tyrosines within the Trk cytoplasmic domain. Using pheochromocytoma-derived cell lines, we show that individual tyrosines within the nerve growth factor receptor TrkA are phosphorylated in a non-coordinate fashion following receptor activation. The non-coordinate response of these tyrosines reflects their separate functions in regulating the catalytic and signaling activities of Trk receptors. The differential utilization of distinct sites on Trk receptor tyrosine kinases suggests that the receptor can specify both the timing and the nature of neurotrophin-stimulated signal transduction pathways. Moreover, we show that these Trk autophosphorylation sites, which have hitherto been mapped and characterized only in non-neuronal cell lines, are activated in normal neurons in response to ligand stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702742     DOI: 10.1074/jbc.271.33.20175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.

Authors:  D Y Choi; J J Toledo-Aral; R Segal; S Halegoua
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Signaling of neuronal cell death by the p75NTR neurotrophin receptor.

Authors:  E J Coulson; K Reid; P F Bartlett
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

3.  A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons.

Authors:  M F DeFreitas; P S McQuillen; C J Shatz
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  A function-structure model for NGF-activated TRK.

Authors:  M E Cunningham; L A Greene
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

5.  Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

Authors:  Henri Autio; Kert Mätlik; Tomi Rantamäki; Lothar Lindemann; Marius C Hoener; Moses Chao; Urmas Arumäe; Eero Castrén
Journal:  Neuropharmacology       Date:  2011-07-30       Impact factor: 5.250

6.  Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands.

Authors:  S Maliartchouk; H U Saragovi
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

7.  Trk receptors function as rapid retrograde signal carriers in the adult nervous system.

Authors:  A Bhattacharyya; F L Watson; T A Bradlee; S L Pomeroy; C D Stiles; R A Segal
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

8.  Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance.

Authors:  Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP: MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; C William Shuttleworth; Surojit Paul
Journal:  J Biol Chem       Date:  2015-11-16       Impact factor: 5.157

10.  Vav3-deficient mice exhibit a transient delay in cerebellar development.

Authors:  Celia Quevedo; Vincent Sauzeau; Mauricio Menacho-Márquez; Antonio Castro-Castro; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.